AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $78,655,000 | -0.2% | 6,069,032 | 0.0% | 0.80% | +8.0% |
Q1 2021 | $78,806,000 | +19.9% | 6,069,032 | +27.7% | 0.74% | +28.2% |
Q4 2020 | $65,748,000 | -6.1% | 4,754,000 | 0.0% | 0.58% | -34.7% |
Q3 2020 | $70,026,000 | +260.2% | 4,754,000 | +297.4% | 0.88% | +221.2% |
Q2 2020 | $19,441,000 | +0.2% | 1,196,347 | -10.5% | 0.27% | -16.0% |
Q1 2020 | $19,393,000 | -59.2% | 1,336,547 | -43.0% | 0.33% | -51.9% |
Q4 2019 | $47,519,000 | +152.0% | 2,345,447 | -33.6% | 0.68% | +89.4% |
Q3 2019 | $18,856,000 | -18.8% | 3,531,002 | 0.0% | 0.36% | -0.6% |
Q2 2019 | $23,234,000 | +13.5% | 3,531,002 | +12.1% | 0.36% | +13.6% |
Q1 2019 | $20,474,000 | +2071.2% | 3,149,810 | +1781.4% | 0.32% | +2781.8% |
Q2 2018 | $943,000 | -71.0% | 167,419 | -73.3% | 0.01% | -72.5% |
Q1 2018 | $3,250,000 | -60.1% | 626,275 | -65.2% | 0.04% | -61.2% |
Q4 2017 | $8,142,000 | -27.8% | 1,797,400 | 0.0% | 0.10% | -4.6% |
Q3 2017 | $11,270,000 | +2.3% | 1,797,400 | 0.0% | 0.11% | -6.1% |
Q2 2017 | $11,018,000 | -16.5% | 1,797,400 | 0.0% | 0.12% | -23.3% |
Q1 2017 | $13,193,000 | – | 1,797,400 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |